KRAS(G12D) His Tag Protein, Human Drug Target Proteins The sequence of addition of

The sequence of addition of the terminating solution should be the same as that of the developer as possible

also known as apoptosis regulator BAK

This product is mainly applied to the determination of paired full-length VDJ sequences in human single B cells

FcγRI (CD64)

-20 to -70℃ under sterile conditions after reconstitution

KRAS(G12D) His Tag Protein, Human Drug Target Proteins The sequence of addition ofProduct Specification Species Human Synonyms K Ras 2, Ki Ras, c K ras, c Ki ras, GTPase KRas, KRAS2, RASK2 Accession P01116 2 Amino Acid Sequence Thr2 Cys185G12Dwith His Tag at the C Terminus Expression System E. coli Molecular Weight 20 25kDa (Reducing) Purity 95% by SDS PAGE Conjugation Unconjugated Tag His Tag Physical Appearance Liquid Storage Buffer 20 mM Tris, 150 mM NaCl, 1 mM DTT, PH7. 4 ,10% glycerol Reconstitution Reconstitute at 0. 1 1 mg